Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficiency) (Unaudited) (Parenthetical)

v3.8.0.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficiency) (Unaudited) (Parenthetical)
3 Months Ended
Mar. 31, 2018
USD ($)
Statement of Stockholders' Equity [Abstract]  
Proceeds from public offering $ 18,504,320
Issuance costs $ 3,623,505